| 5.81 Data as of 4:00pm ET | -0.09 / -1.53%Today’s Change | 3.76 Today|||52-Week Range 7.44 | -9.64% Year-to-Date |
| Varian Links With Siemens Systems - Analyst Blog Jun 14 / Zacks.com | Accuray Expands in France - Analyst Blog Jun 07 / Zacks.com |
| The 5 Worst Medical Device Stocks of 2013 Jun 14 / MotleyFool.com | 1 Reason Accuray May Be Headed for a Slowdown Jun 05 / MotleyFool.com |
| Previous close | 5.90 |
| Today’s open | 5.88 |
| Day’s range | 5.80 - 5.93 |
| Volume | 415,999 |
| Average volume (3 months) | 938,691 |
| Market cap | $437.3M |
| Dividend yield | -- |
| Earnings growth (last year) | -131.82% |
| Earnings growth (this year) | -83.54% |
| Earnings growth (next 5 years) | +72.00% |
| Revenue growth (last year) | +84.10% |
| P/E ratio | NM |
| Price/Sales | 1.18 |
| Price/Book | 2.17 |
| Today’s change | Today’s % change | |
|---|---|---|
| CYNOCynosure Inc | -0.28 | -1.15% |
| IVCInvacare Corp | -0.40 | -2.62% |
| IMMUImmunomedics Inc | +0.13 | +3.02% |
| TEARTearLab Corp | -0.11 | -0.98% |
| Next reporting date | September 23, 2013 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $409.2M |
| Annual profit (last year) | -$72.0M |
| Net profit margin | -17.60% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Joshua H. Levine |
Executive VP-Engineering & Global Operations Robert P. Ragusa, MBA |
Corporate headquarters Sunnyvale, California |
